COX-2 specific inhibitors: safer anti-inflammatory therapy?

COX-2 specific inhibitors: safer anti-inflammatory therapy? A new class of anti-inflammatory agents that is as effectual as conventional NSAIDs but carries less risk for the upper gastrointestinal tract has been released lately in Australia. The COX-2 specific inhibitors selectively block the formation of prostaglandins involved in inflammation and discomfort while sparing those involved in protecting the abdomen from ulceration.A culmination of almost 25 years of study on noise-induced hearing reduction – a growing medical concern that affects more than 12 % of American troops returning from conflicts around the globe – will be provided Sept. 9 at the American Academy of Otolaryngology-Head & Throat Surgery annual conference in Washington, D.C. Led by Michael Seidman, M.D., the research team is the first to recognize how acoustic trauma from machinery and explosive devices damages the inner ear cells and reduces cell growth, very much like age-related hearing loss. Improvised explosive devices, aircraft and additional weaponry being utilized by the military are deafening our troops frankly, says Dr. Seidman, director of the Division of Otologic/Neurotologic Surgery in the Section of Otolaryngology-Head & Neck Medical procedures at Henry Ford Hospital.